[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337061-105":59,"doc-detail-337061-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","serous-tubal-intraepithelial-carcinoma-stic-a-review-of-the-literature-on-the-incidence-at-the-time-of-prophylactic-surgery","Serous Tubal Intraepithelial Carcinoma (STIC) - A Review of the Literature on the Incidence at the Time of Prophylactic Surgery","","Serous tubal intraepithelial carcinoma (STIC) is an early pre-invasive cancerous lesion in the fallopian tubes, often at the fimbrial end, strongly linked to high-grade serous carcinoma (HGSC), an aggressive ovarian cancer subtype. STIC is considered a precursor, frequently associated with TP53 mutations and a p53 signature, particularly in BRCA mutation carriers. This review evaluates incidence data (2016–2023) from studies of BRCA-positive and BRCA-negative patients undergoing preventive salpingo-oophorectomy, extracting patient characteristics, interventions, outcomes, and STIC incidence. Nine international studies were included, reporting an overall STIC incidence of 7.31% and ~6.08% in BRCA-mutated women, with TP53 signature presence significantly associated with STIC.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/serous-tubal-intraepithelial-carcinoma-stic-a-review-of-the-literature-on-the-incidence-at-the-time-of-prophylactic-surgery/337061/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/serous-tubal-intraepithelial-carcinoma-stic-a-review-of-the-literature-on-the-incidence-at-the-time-of-prophylactic-surgery/337061.png","ImageObject",300,407,{"name":92,"@type":93},"Evangeline","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is STIC and how is it related to HGSC and ovarian cancer?","Question",{"text":112,"@type":113},"STIC is an early pre-invasive cancerous lesion in the fallopian tubes, often at the fimbrial end. It is strongly associated with high-grade serous carcinoma (HGSC), an aggressive ovarian cancer subtype and a major cause of gynecologic cancer mortality.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does the TP53 mutation/p53 signature relate to STIC incidence?",{"text":117,"@type":113},"STIC development is frequently linked to TP53 mutations that produce a p53 signature. The review reports that the presence of the TP53 signature was significantly associated with STIC occurrence.",{"name":119,"@type":110,"acceptedAnswer":120},"What incidence rates of STIC were reported in patients undergoing preventive salpingo-oophorectomy?",{"text":121,"@type":113},"Across included studies, the overall incidence of STIC among all women was 7.31%. In BRCA-mutated women, the incidence was approximately 6.08%.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},337061,1790192923,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},13056703019662,"https://ap-avatar.wpscdn.com/avatar/be000253a8e92610077?_k=1778726343310543188","Review  \nSerous Tubal Intraepithelial Carcinoma (STIC): A Review of the Literature on the Incidence at the Time of Prophylactic Surgery  \nDaniela Luvero 1, *, Roberto Angioli 1,2, Erika Notaro 1, Francesco Plotti 1,2, Corrado Terranova 1,2,  \nAnna Maria Angioli 2, Asia Festa 1, Andi Stermasi 1, Serena Manco 1, Miriana Diserio 1 and Roberto Montera 1,2  \nCitation: Luvero, D.; Angioli, R.; Notaro, E.; Plotti, F.; Terranova, C.; Angioli, A.M.; Festa, A.; Stermasi, A.; Manco, S.; Diserio, M.; et al. Serous Tubal Intraepithelial Carcinoma (STIC): A Review of the Literature on the Incidence at the Time of Prophylactic Surgery. Diagnostics 2024, 14, 2577. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/diagnostics14222577](10.3390/diagnostics14222577)  \nAcademic Editor: Cinzia Giacometti  \nReceived: 16 October 2024  \nRevised: 10 November 2024  \nAccepted: 14 November 2024  \nPublished: 16 November 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Department of Gynecology, Fondazione Policlinico Universitario Campus Bio Medico, Via Alvaro del Portillo 200, 00128 Roma, Italy  \n2 Research Unit of Gynecology, Department of Medicine and Surgery, Università Campus Bio Medico, Via Alvaro del Portillo 21, 00128 Roma, Italy  \n* Correspondence: [d.luvero@policlinicocampus.it](d.luvero@policlinicocampus.it); Tel.: +39-06-225-411-452  \nAbstract: Background: Serous tubal intraepithelial carcinoma (STIC) is an early-stage cancerous lesion found in the fallopian tubes, often at the fimbrial end. It is strongly associated with high-grade serous carcinoma (HGSC), a highly aggressive type of ovarian cancer. STIC is considered a precursor to many HGSC cases, originating in the fallopian tubes. Its development is frequently linked to mutations in the TP53 gene, leading to the formation of a p53 signature, an early abnormality that may progress to HGSC. This signature is more common in BRCA mutation carriers, explaining the higher incidence of STIC in this group. The aim of this review is to evaluate the literature on the incidence of serous tubal intraepithelial carcinoma in patients (both BRCA-positive and BRCAnegative) undergoing preventive salpingo-oophorectomy, analysing the available data and identifying associations between specific characteristics and the onset of STIC. Methods: A comprehensive review of the literature from 2016 to 2023 was conducted using PubMed, focusing on studies analysing the incidence of STIC in BRCA-positive patients undergoing preventive salpingo-oophorectomy. Data on patient characteristics, interventions, outcomes, and incidence of STIC were extracted and analysed. Results: Nine international studies were included in the review, reporting varying incidences of STIC among patients undergoing salpingo-oophorectomy. The overall incidence of STIC in all the women included in the studies was 7.31%, while that in the BRCA-mutated women was approximately 6.08% . Notably, the presence of the TP53 signature was significantly associated with the occurrence of STIC. Conclusions: The etiopathogenesis of STIC involves complex interactions between genetic, environmental, and molecular factors. Further research is needed to fully understand its mechanismsand identify additional risk factors beyond BRCA mutations. Establishing a national database of STIC cases could facilitate future research and improve patient outcomes.  \nKeywords: STIC; prophylactic surgery; ovarian cancer; HGSC; BRCA mutations  \n1. Introduction  \nSerous tubal intraepithelial carcinoma (STIC) is a type of pre-invasive or early-stage cancerous lesion found in the epithelial cells lining the fallopian tubes, more specifically atthe fimbria","cbCaiq1H5Y4b4Whl","https://ap.wps.com/l/cbCaiq1H5Y4b4Whl","pdf",251524,11,"English","# Abstract\n# Keywords\n# Introduction\n## Epidemiology and clinical burden of HGSC\n## Proposed origins of HGSC and role of STIC\n## Progression timeline and precursor rationale\n## Molecular and experimental evidence\n# Methods\n# Results\n# Conclusions","[{\"question\":\"What is STIC and how is it related to HGSC and ovarian cancer?\",\"answer\":\"STIC is an early pre-invasive cancerous lesion in the fallopian tubes, often at the fimbrial end. It is strongly associated with high-grade serous carcinoma (HGSC), an aggressive ovarian cancer subtype and a major cause of gynecologic cancer mortality.\"},{\"question\":\"How does the TP53 mutation/p53 signature relate to STIC incidence?\",\"answer\":\"STIC development is frequently linked to TP53 mutations that produce a p53 signature. The review reports that the presence of the TP53 signature was significantly associated with STIC occurrence.\"},{\"question\":\"What incidence rates of STIC were reported in patients undergoing preventive salpingo-oophorectomy?\",\"answer\":\"Across included studies, the overall incidence of STIC among all women was 7.31%. In BRCA-mutated women, the incidence was approximately 6.08%.\"}]","Serous Tubal Intraepithelial Carcinoma (STIC) - A Review of the Literature on the Incidence at the Time of Prophylactic Surgery | PDF",1790017597,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f72d1249834fc5e8ac87f7ae741e97a3.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4db35078b1f9c17e52178c9909816a48.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e28b31d1970e9e764b969412437dddb8.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e586cbeee825e2b0eb069ac6017c69bf.webp",980,1385]